06Mar/14

Agenus to advance three checkpoint modulator antibodies into development – Pharmaceutical Business Review

March 6, 2014Antibodiesadmin

Agenus to advance three checkpoint modulator antibodies into development
Pharmaceutical Business Review
The parties also have ongoing programs to discover and develop other immune checkpoint modulator antibodies, including OX40 agonists and antagonists of LAG-3, TIM-3 and PD-1. Agenus chief scientific officer Dr Robert B Stein noted GITR, a checkpoint …
Ludwig and Agenus to advance three checkpoint modulator antibodies into …HealthCanal.com
Agenus Inc (AGEN) news: Agenus’ CEO Discusses Q4 2013 Results – Earnings …Seeking Alpha
Agenus reports net loss attributable to common stockholders of $5.8 million …News-Medical.net

all 13 news articles »

06Mar/14

South African scientists map HIV antibodies in vaccine hunt – Yahoo South Africa

March 6, 2014Antibodiesadmin

Yahoo South Africa

South African scientists map HIV antibodies in vaccine hunt
Yahoo South Africa
The scientists have been studying one woman’s response to HIV infection from stored samples of her blood and isolated the antibodies that she developed, said Lynn Morris, head of the virology unit at the NICD. The study, by a consortium of scientists …

05Mar/14

Subcutaneous rituximab noninferior to IV formulation in follicular lymphoma – Healio

March 5, 2014Monoclonal Anti-CD20 Antibodiesadmin

Subcutaneous rituximab noninferior to IV formulation in follicular lymphoma
Healio
Subcutaneous rituximab appeared noninferior to the IV formulation in patients with follicular lymphoma, conferring similar outcomes without increased safety issues, according to preliminary study results. The SABRINA study — a two-stage, randomized, …

05Mar/14

B-cells aggravate autoimmune diseases – Science Codex

March 5, 2014Monoclonal Anti-CD20 Antibodiesadmin

Science Codex

B-cells aggravate autoimmune diseases
Science Codex
In cases of rheumatoid arthritis in which conventional treatments are ineffective, patients can be treated with the drug Rituximab. The drug destroys all B-cells in the body and will thus at least halt the progress of the disease. “The B-cells produced …

and more »

05Mar/14

Fc Protein and Glycoengineered Antibodies Market – PharmiWeb.com (press release)

March 5, 2014Antibodiesadmin

Fc Protein and Glycoengineered Antibodies MarketPharmiWeb.com (press release)Engineered antibodies are antibody based therapeutics which are gaining increasing attention from both large and small pharmaceutical companies. Developed through introduction…

05Mar/14

Fc Protein and Glycoengineered Antibodies Market – PR Newswire (press release)

March 5, 2014Antibodiesadmin

Fc Protein and Glycoengineered Antibodies MarketPR Newswire (press release)Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies. Developed through introduction …

05Mar/14

Agenus to Advance Three Checkpoint Modulator Antibodies into Development – Wall Street Journal

March 5, 2014Antibodiesadmin

Agenus to Advance Three Checkpoint Modulator Antibodies into DevelopmentWall Street JournalLudwig Cancer Research and Agenus Inc. (NASDAQ: AGEN) today announced the selection of three monoclonal antibody checkpoint modulators (CPMs) that Agenus is adva…

05Mar/14

Agenus to Advance Three Checkpoint Modulator Antibodies into Development – MarketWatch

March 5, 2014Antibodiesadmin

Agenus to Advance Three Checkpoint Modulator Antibodies into Development
MarketWatch
We are encouraged to have identified high-quality agonist antibodies for this very competitive target, something that has proven difficult for many other companies,” said Robert B. Stein, MD, PhD, Chief Scientific Officer of Agenus. “Furthermore, it is …
Agenus reports net loss attributable to common stockholders of $5.8 million …News-Medical.net

all 6 news articles »

05Mar/14

New research on potent HIV antibodies has opened up possibilities – EurekAlert (press release)

March 5, 2014Antibodiesadmin

New research on potent HIV antibodies has opened up possibilities
EurekAlert (press release)
The discovery of how a KwaZulu-Natal woman’s body responded to her HIV infection by making potent antibodies (called broadly neutralising antibodies, because they are able to kill multiple strains of HIV from across the world), was reported today by …

05Mar/14

Weill Cornell Researchers Find a Better Alternative to Chemotherapy for Leukemia – Cornell University The Cornell Daily Sun (blog)

March 5, 2014Monoclonal Anti-CD20 Antibodiesadmin

Cornell University The Cornell Daily Sun (blog)Weill Cornell Researchers Find a Better Alternative to Chemotherapy for LeukemiaCornell University The Cornell Daily Sun (blog)The double-blind, randomized, placebo-controlled study compared the efficacy o…

Category Archives: Antibodies